235 related articles for article (PubMed ID: 32209694)
1.
Teruya S; Hiramatsu Y; Nakamura K; Fukui-Miyazaki A; Tsukamoto K; Shinoda N; Motooka D; Nakamura S; Ishigaki K; Shinzawa N; Nishida T; Sugihara F; Maeda Y; Horiguchi Y
mBio; 2020 Mar; 11(2):. PubMed ID: 32209694
[TBL] [Abstract][Full Text] [Related]
2. Production of Highly Active Recombinant Dermonecrotic Toxin of
Stanek O; Linhartova I; Holubova J; Bumba L; Gardian Z; Malandra A; Bockova B; Teruya S; Horiguchi Y; Osicka R; Sebo P
Toxins (Basel); 2020 Sep; 12(9):. PubMed ID: 32942577
[TBL] [Abstract][Full Text] [Related]
3. Molecular aspects of Bordetella pertussis pathogenesis.
Locht C
Int Microbiol; 1999 Sep; 2(3):137-44. PubMed ID: 10943406
[TBL] [Abstract][Full Text] [Related]
4. Genomics of Bordetella pertussis toxins.
Antoine R; Raze D; Locht C
Int J Med Microbiol; 2000 Oct; 290(4-5):301-5. PubMed ID: 11111902
[TBL] [Abstract][Full Text] [Related]
5. Immunological and protective effects of Bordetella bronchiseptica subunit vaccines based on the recombinant N-terminal domain of dermonecrotic toxin.
Wang C; Liu L; Zhang Z; Yan Z; Yu C; Shao M; Jiang X; Chi S; Wei K; Zhu R
Int Immunopharmacol; 2015 Oct; 28(2):952-9. PubMed ID: 26337750
[TBL] [Abstract][Full Text] [Related]
6. Design of a Quantitative LC-MS Method for Residual Toxins Adenylate Cyclase Toxin (ACT), Dermonecrotic Toxin (DNT) and Tracheal Cytotoxin (TCT) in
Szymkowicz L; Gerard J; Messham B; Tam WWV; James DA
Toxins (Basel); 2021 Oct; 13(11):. PubMed ID: 34822547
[TBL] [Abstract][Full Text] [Related]
7. Role of Major Toxin Virulence Factors in Pertussis Infection and Disease Pathogenesis.
Scanlon K; Skerry C; Carbonetti N
Adv Exp Med Biol; 2019; 1183():35-51. PubMed ID: 31376138
[TBL] [Abstract][Full Text] [Related]
8. [Construction of the genetically attenuated bacteria Bordetella pertussis devoid of dermonecrotic toxin activity and producing modified nontoxic pertussis toxin form].
Siniashina LN; Siniashina LS; Semin EG; Amelina IP; Karataev GI
Mol Gen Mikrobiol Virusol; 2010; (3):31-6. PubMed ID: 20886687
[TBL] [Abstract][Full Text] [Related]
9. Modulation of Pertussis and Adenylate Cyclase Toxins by Sigma Factor RpoE in Bordetella pertussis.
Barbier M; Boehm DT; Sen-Kilic E; Bonnin C; Pinheiro T; Hoffman C; Gray M; Hewlett E; Damron FH
Infect Immun; 2017 Jan; 85(1):. PubMed ID: 27849178
[TBL] [Abstract][Full Text] [Related]
10. Association of Bordetella dermonecrotic toxin with the extracellular matrix.
Fukui-Miyazaki A; Kamitani S; Miyake M; Horiguchi Y
BMC Microbiol; 2010 Sep; 10():247. PubMed ID: 20868510
[TBL] [Abstract][Full Text] [Related]
11. Pertussis toxin and extracytoplasmic adenylate cyclase as virulence factors of Bordetella pertussis.
Weiss AA; Hewlett EL; Myers GA; Falkow S
J Infect Dis; 1984 Aug; 150(2):219-22. PubMed ID: 6088647
[TBL] [Abstract][Full Text] [Related]
12. Dermonecrotic toxin and tracheal cytotoxin, putative virulence factors of Bordetella avium.
Gentry-Weeks CR; Cookson BT; Goldman WE; Rimler RB; Porter SB; Curtiss R
Infect Immun; 1988 Jul; 56(7):1698-707. PubMed ID: 3384473
[TBL] [Abstract][Full Text] [Related]
13. Identification of a receptor-binding domain of Bordetella dermonecrotic toxin.
Matsuzawa T; Kashimoto T; Katahira J; Horiguchi Y
Infect Immun; 2002 Jul; 70(7):3427-32. PubMed ID: 12065482
[TBL] [Abstract][Full Text] [Related]
14. Both adenylate cyclase and hemolytic activities are required by Bordetella pertussis to initiate infection.
Khelef N; Sakamoto H; Guiso N
Microb Pathog; 1992 Mar; 12(3):227-35. PubMed ID: 1614333
[TBL] [Abstract][Full Text] [Related]
15. Genetic studies of the molecular basis of whooping cough.
Weiss AA; Hewlett EL; Myers GA; Falkow S
Dev Biol Stand; 1985; 61():11-9. PubMed ID: 2872097
[TBL] [Abstract][Full Text] [Related]
16. Bordetella dermonecrotic toxin undergoes proteolytic processing to be translocated from a dynamin-related endosome into the cytoplasm in an acidification-independent manner.
Matsuzawa T; Fukui A; Kashimoto T; Nagao K; Oka K; Miyake M; Horiguchi Y
J Biol Chem; 2004 Jan; 279(4):2866-72. PubMed ID: 14597616
[TBL] [Abstract][Full Text] [Related]
17. Characterization of murine lung inflammation after infection with parental Bordetella pertussis and mutants deficient in adhesins or toxins.
Khelef N; Bachelet CM; Vargaftig BB; Guiso N
Infect Immun; 1994 Jul; 62(7):2893-900. PubMed ID: 7999145
[TBL] [Abstract][Full Text] [Related]
18. Development of a targeted nanoLC-MS/MS method for quantitation of residual toxins from Bordetella pertussis.
Szymkowicz L; Wilson DJ; James DA
J Pharm Biomed Anal; 2020 Sep; 188():113395. PubMed ID: 32526622
[TBL] [Abstract][Full Text] [Related]
19. Characterization of the dermonecrotic toxin in members of the genus Bordetella.
Walker KE; Weiss AA
Infect Immun; 1994 Sep; 62(9):3817-28. PubMed ID: 8063398
[TBL] [Abstract][Full Text] [Related]
20. The Eukaryotic Host Factor 14-3-3 Inactivates Adenylate Cyclase Toxins of Bordetella bronchiseptica and B. parapertussis, but Not B. pertussis.
Fukui-Miyazaki A; Toshima H; Hiramatsu Y; Okada K; Nakamura K; Ishigaki K; Shinzawa N; Abe H; Horiguchi Y
mBio; 2018 Aug; 9(4):. PubMed ID: 30154257
[No Abstract] [Full Text] [Related]
[Next] [New Search]
